Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICADO: Tumor Microenvironment and Immune System in Digestive Cancers
NCT04707365Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2021
- Primary completion
- Mar 2035
01
Overview
Open-label, single-arm trial in colorectal cancer (CRC), pancreatic cancer (PC) and biliary tract cancer (BTC), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Overall Survival at 10 years. Planned start Mar 2021; status: not yet recruiting.
02
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT04707365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707365.